Stocks surged higher on Tuesday, ignited by strong earnings at the open and then fuelled by a resurgence in the heavily-weighted information technology sector (3.0%) throughout the day. The S&P 500 rocketed through its 200-day moving average, closing 2.2% higher and reducing its October loss to 3.6%.
As for the other major averages, the Dow Jones Industrial Average jumped 2.2%, the Nasdaq Composite surged 2.9%, and the Russell 2000 advanced 2.8%. The Dow and the Nasdaq both closed above their 200-day moving averages, but the Russell 2000 did not.
Our take on Netflix (NFLX) earnings and much more.Read More
With the October 17 fast approaching we highlight one of our top Cannabis picks, Aphria (AOHQF). We like Aphria for several reasons one being its capacity. The company currently can grow 35,000 kilograms of cannabis per year. However, Aphria is boosting its annual production capacity to 255,000 kilograms next year.
The largest immediate opportunity for Aphria (AOHQF) to use this significant production capacity is in the Canadian recreational marijuana market scheduled to open this week. Aphria (AOHQF) has supply agreements for with eight provinces and territories so far, including Ontario which is the largest and probably most affluent in Canada.Read More
Bitcoin (BTC) has taken a significant beating in the recent months. Just last night we saw the price of Bitcoin (BTC) tank more than 5% on what seemed to be no reason at all. Technically speaking Bitcoin has been struggling to break out of this $6500 – $6800 range. We will not dwell into the details at though why, however, we do have a trading plan for our readers.
Generally, the low $6100 level has been strong support for Bitcoin (BTC), yet it is unclear whether that will hold to be true or not. Looking back we can see that Bitcoin (BTC) has bounced from $6100 to at least mid-$6000s to low $7000s. The space has been pretty boring in the last little while and we’ve come up with a play to make it a bit more exciting for our readers.Read More
Stocks closed lower in Thursday’s trading session, seemingly an extension of yesterday, attributed to US Treasury yields reaching multi-year highs. The S&P 500 was down as much as 1.4% in intraday trade, but bounced back late to close at down 0.8%. The Dow Jones Industrial Average closed down 0.8%, Nasdaq Composite closed down 1.8%. Last but not least the Russell 2000, continued to struggle again losing 1.5% on Thursday, extending its weekly loss to 2.9%. CBOE Volatility Index, generally used as an “investor fear gauge”, shot up to 32.9% before closing up 21.8%.
We have been following Sarepta Therapeutics Inc. (SRPT) for some time. On October 4th they presented at the International Congress of the World Muscle Society (WMS) an update on the Phase 1/2 micro-dystrophin gene therapy data (n=4; cohort B) in Duchenne muscular dystrophy (DMD), here are our thoughts.Read More
The Italian drama continued on Tuesday, yet it may not have negatively weigh on investors, leaving the S&P 500 unchanged. The Dow Jones Industrial Average outperformed, climbing 0.5% to a new all-time high, while the Nasdaq Composite lagged for the second day in a row, closing 0.5% lower. The Russell 2000 continued to struggle on Tuesday, closing 1.0% lower, thus extending the weekly loss to -2.4%.
Today we dig deeper into the recent sell-off seen in Teva Pharmaceutical (TEVA).Read More
On June 21, 2018, the Government of Canada announced that Bill C-45 received Royal Assent and that it will come into force on October 17, 2018. Management has invested significant effort in securing channels into the future regulated recreational markets. This, in addition to various states in the US beginning to work towards legalization of cannabis, has resulted in growing interest from investors. This effect can be magnified if Congress passes the 2018 Farm Bill which will fully legalize commercial hemp production in the US. Various other countries have also worked to remove various government red tape surrounding cannabis.
Marijuana or cannabis is one of the most popular recreational drugs used worldwide. It has been estimated that more than 175 million people between the age of 15 to 64 have used the drug at least once. Medical cannabis, refers to use of the plant’s cannabinoids as medical therapy to treat disease or alleviate symptoms. Cannabinoids can be administered orally, inhaled, smoked, mixed with food, or made into tea. They active compound, cannabinoids, can be taken in the herbal form, extracted naturally or synthetically created in a lab.
In this post we dissect three of our favourite cannabis stocks to own in 2018.Read More